Population structure
The estimated mid-year population in1996 was 2 135 853 of which 1 593 769 were Omanis and 542 084 were Non-Omanis. The Omani population shows a sex ratio of 963 females per 1000 males. About 16.0% of the population is under-5 years and 45.0% is under-15 years. Only 3.0% of the total Omani population is above the age of 65 years. While, the estimated mid-year population in 2015 was 4 159 102 of which 2 344 946 were Omanis and 1 814 156 were Non-Omanis. The Omani population showed a sex ratio of 979 females per 1000 males. About 14.9% of the population were under-5 years and 35.7% were under-15 years. The population above 65 years increased to 4.3% [ Figure 2 ].
Oman national cancer registry
The Oman National Cancer Registry was established in 1985 as a hospital-based registry. Only cases treated in tertiary hospitals were registered. In 1996, with the establishment of the department of Non-Communicable Diseases Surveillance and Control, the cancer registry was transferred and started functioning under the Directorate General of Primary Health Care. New cancer notification forms were developed and distributed to all regional hospitals and institutions. In 2000, the registration form was simplified, printed, and distributed to all institutions that could potentially report cancer cases. Three trained cancer registrars are responsible for data collection, coding, and data entry of all reported cases.
M ET H O D S

Data collection a) Active collection
Active collection involves the registry personnel visiting different sources and abstracting data on cancer registry forms. Being the largest tertiary center for diagnosis and treatment of cancer, registrars visit the Royal Hospital twice a week and abstract data on the notification forms. Similarly, other tertiary hospitals like Khoula Hospital and Al-Nahdha Hospital are visited once a month.
Data on patients undergoing chemotherapy and radiotherapy treatments are also collected from the National Oncology Centre which was established within the Royal Hospital in November 2004. Data of patients diagnosed with cancer abroad are traced through oncology out-patient registers at the Royal Hospital, and subsequently, data are extracted from their case notes. Detailed list of patients sent abroad for cancer treatment through the Ministry of Health system are obtained from the department of Treatment Abroad.
b) Passive reporting
Cancer notification was made mandatory in 2001 through a Ministerial Decision (4/2001) . When a case of cancer is diagnosed, the attending physician of the relevant specialty or the medical records department at the regional hospital completes the notification forms and sends them to the registry. Other institutions like the Armed Forces Hospital and Sultan Qaboos University Hospital have similar passive reporting. In 2017, the above Ministerial Decision was updated (222/2017) to include all health (Civil or Military) institutions in Oman including private hospitals. These institutions are frequently visited by the cancer registrars for data extraction of patients diagnosed in them. Na jla A . Al-l awati, et al.
International Classification of Diseases for Oncology (ICDO-2) with topography 'C' and morphology 'M' codes. Initially, data were entered using CanReg3 software, (International Agency for Research on Cancer (IARC), lyon, France). Subsequently, CanReg4 software and ICDO-3 were used in 2003. Duplicate entries were checked by this software to avoid the same case being registered more than once. In 2016, the registry software was upgraded to CanReg5 (version 00.40). 1 For this report, we used CanReg5 (version 00.42). Validity checks were performed for consistency between site/histology, gender/site, and age/site/histology combinations using the same version.
Completeness of data reporting
Data are obtained from all hospitals with histopathology/cytology and hematology laboratories (Royal, Al-Nahdha, Khoula, Sultan Qaboos University, and Sohar Hospitals) from copies of patients' reports diagnosed with cancer to the registry. Since the mid of 2001, Sultan Qaboos University and Armed Forces Hospitals histopathology laboratories have also started sending reports.
Since the establishment of the new National Oncology Centre, chemotherapy and radiotherapy weekly logs are included in data collection of all patients attending these two modalities of treatments. Monthly hospital admission and discharge lists sent from all tertiary and regional hospitals to the Registry office to extract data of patients admitted for or discharged with a diagnosis of cancer and patients status are updated in the Registry (alive/dead).
A list of all cancer patients attending for chemotherapy sessions in all tertiary hospitals is also obtained. Details of missing data are sought from all of the above sources so that the registry can be updated.
Data analysis
The analysis below is limited to Omani nationals in the ONCR database. Non-Omanis working in Oman represent a skewed population from a wide range countries from all over the world, making determination of denominator for the calculation of incidence rates among them a complex exercise.
The data was first checked for consistency and validity using CanReg5 (version 00.42, build1566 (IARC 2008 .
1 Frequency distribution and incidence tables were generated for Omani subjects, using this software. Data for individual cancers were then exported to CSV format to Stata software (version 14.2, Stata Corporation, TX, USA) for analysis of incidence by region, gender and morphology, and topography. Bar diagrams and graphs are generated using Excel version 2013 (Microsoft Corporation).
The average annual incidence and crude rates for the entire 20 years period were generated using CanReg5. The total average incidence and crude rates were calculated manually using Excel. Average of mid-year population of the years 2005 and 2006 were used to estimate crude rates and agestandardized rates were calculated using the World Standard Population of Segi. 2 Population denominators used for the calculations of incidence rates (by 5-year age group, gender, and region) were obtained from the Ministry of Health's Annual Health Reports. 3 
Age-standardized rate (ASR)
Age-standardized rates (ASRs) were obtained using the World Standard Population of Segi 2 to adjust the crude incidence rates (CRs) and to remove the confounding effect of age [ Table 2 and Figure 3 ]. If we consider the CR of 49.4 per 100 000 people for 1996 to continue at same rate then it would be expected that the total cases in 2015 would be 1158 cases. However, the total cases were 1632 cases which means that the incidence rate has increased. There was a rise in the CR by 41% between 1996 and 2015. This increase was higher (37.9%) between 2010 and 2015 compared to 2.3% 1996-2010.
There appears to be a true increase in the incidence of cancer in Oman which may be attributed to population aging. In 1996, about 0   200   400   600   800   1000   1200   1400   1600   1800  Total  Female  Male   2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996 Year Frequency cases Figure 3 : Frequancy of cancer cases by gender, Oman, 1996 Oman, -2015 16.0% of the population were under-5 years, 45.0% were under-15 years, and only 3.0% were above the age of 65 years. In 2015, the proportion of under-5 years were 14.9%, under-15 years reached 37.5% while the proportion of peopled aged 65 and above increased to 4.3%.
life expectancy in Oman has also increased from 72.0 years at birth in 1996 to 76.4 years in 2015. This rise in cancer incidence cases may be attributed to a number of factors, mainly the improvement in health care services over the past five decades including the introduction of an early detection program for breast cancer, the advanced in diagnostic and treatment modalities, and better public awareness about the cancer by non-governmental associations (introduced mammogram mobile unit as an outreach program into various regions of Oman). Other factors that might explain the increase in the incidence rates is the epidemiologic transition due to the rapid socioeconomic changes resulting in an increase in unhealthy lifestyles (tobacco use and its easy availability, physical inactivity, and unhealthy food habits). Oman, 1996 Oman, -2015 Between January 1996 and December 2015, there were 21 002 newly diagnosed cases of cancer among Omanis, of which 10 723 (55.1%) were in men and 10 279 (48.9%) in women. On average, 1050 cases were reported annually in Oman. The average annual crude incidence rate was 55.1 per 100 000 males versus 54.2 per 100 000 females. The average annual ASRs were 105.2 and 96.3 per 100 000 males and females, respectively. The average annual CRs were 55.1 per 100 000 Omani males and 54.2 per 100 000 Omani females. The average annual world ASRs were 105.2 and 96.3 per 100 000 Omani males and females, respectively [ Table 2 ].
Cancer incidence in
Overall, there was an observed gradual decline in the trend of average annual ASR for Omani male over the 20-year period. On the other hand, the trend of average annual ASR for Omani females increased gradually over the same period [ Figure 4 ]. The average annual age-specific incidence rates were observed to increase dramatically with advancing age in both sexes [ Figure 5 ]. Tables 3 and 4 illustrate the frequency of incidence cases by age group and gender in Omanis for the period 1996-2015. While, tables 5 and 6 demonstrate ASRs in Omani males and females for the same period. Additionally, tables 7 and 8 show ASR by year, from 1996 to 2015, respectively.
Common cancer among Omanis
Over the 20-year period (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) , breast cancer was the leading cancer among Omanis followed by non-Hodgkin's lymphoma, leukemia, colorectal, and thyroid [ Table 9 ].
1) Breast cancer
Breast Cancer was the leading cancer among males and females in Oman and accounted for 10.9% of total malignancies [ Table 9 ]. This malignancy has quadrupled in Oman in 2015 (n = 217) compared to 1996 (n = 53) [ Figure 6 ].
Between 1996 and 2015, there were 2280 cases of breast cancer reported in Oman: 2181 in women and only 99 in men. The ASR for breast cancer in Omani women was 20.8 per 100 000 females with Frequency of incident cases of cancer in males by topography/morphology and age group, Oman, 1996-2015.
-continued Table 4 : Frequency of incident cases of cancer in females by topography/morphology and age group, Oman, 1996-2015. Table 4 : Frequency of incident cases of cancer in females by topography/morphology and age group, Oman, 1996-2015.
-continued Table 5 : Age-standardized incidence rates (ASRs) per 100 000 population of cancer in males by topography/morphology and age group, Oman, 1996-2015.
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Site
All ages Age Age-standardized incidence rates (ASRs) per 100 000 population of cancer in males by topography/morphology and age group, Oman, 1996-2015.
-continued Table 6 : Age-standardized incidence rates (ASRs) per 100 000 population of cancer in females by topography/morphology and age group, Oman, 1996-2015. Table 6 : Age-standardized incidence rates (ASRs) per 100 000 population of cancer in females by topography/morphology and age group, Oman, 1996-2015.
-continued Age-standardized incidence rates (ASRs) per 100 000 population of cancer in females by topography/morphology and age group, Oman, 1996-2015.
-continued Table 7 : Age-standardized incidence rates per 100 000 population in males by topography/morphology and year, Oman, 1996-2015. Age-standardized incidence rates per 100 000 population in males by topography/morphology and year, Oman, 1996-2015.
-continued Table 8 : Age-standardized incidence rates per 100 000 population in females by topography/morphology and year, Oman, 1996 -2015 . Site 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 lip 0 Table 8 : Age-standardized incidence rates per 100 000 population in females by topography/morphology and year, Oman, 1996-2015.
-continued infiltrating ductal carcinoma as the most frequent histopathological type accounting for 73.9% of all breast cancer [ Figure 7 ].
2) Non-Hodgkin's lymphoma
Non-Hodgkin's lymphoma (NHl) is the second most common malignancy among Omanis and accounted for 7.3% of total malignancies. There was an increase of 96.8% in the total of NHl cases reported in Oman in 2015 (n = 122) compared to 1996 (n = 62) [ Figure 8 ]. Between 1996 and 2015, there were 1533 cases of NHl reported in Oman: 932 in men and 601 in women [ Table 9 ]. The world ASR by gender were 8.3 cases per 100 000 Omani males and 5.4 cases per 100 000 females. Figure 9 shows the morphology of NHl reported over past 20 years in both genders.
3) Leukemia
leukemia is the third most common malignancy among Omanis and accounted for 6.8% of total malignancies in both genders [ Table 9 ]. The total number of leukaemia cases reported in Oman was more than doubled in 2015 (n = 97) compared to 1996 (n = 43) [ Figure 10 ].
Between 1996 and 2015, there were 1439 cases of leukemia reported in Oman: 843 in men and 596 in women [ Table 5 and 6]. The ASR by gender were 5.6 cases per 100 000 Omani males and 3.9 cases per 100 000 females. lymphoid leukaemia accounted for 50% of all leukaemia followed by myeloid leukaemia 39.0% and unspecified leukaemia 11.0%.
4) Colorectal cancer
Colorectal cancer is the fourth most common malignancy among Omanis and accounted for 6.6% of total malignancies [ Table 9 ]. There was an increase of more than four folds in the total cases of colorectal cancer reported in Oman in 2015 (n = 148) compared to 1996 (n = 28) [ Figure 11 ]. Table 8 : Age-standardized incidence rates per 100 000 population in females by topography/morphology and year, Oman, 1996-2015.
-continued Between 1996 and 2015, there were 1382 cases of colorectal cancer reported in Oman: 774 in men and 608 in women. The ASR by was 8 per 100 000 and 6.3 cases per 100 000 males and females, respectively [ Table 5 and 6]. Adenocarcinoma was the most frequent histopathological type accounting for 77% of all colorectal cancer [ Figure 12 ].
5) Thyroid cancer
Thyroid cancer is the fifth most common malignancy among Omanis and accounted for 6.1% of all malignancies [ Table 9 ]. There was a four-fold increase in the total cases of thyroid cancer reported in Oman in 2015 (n = 164) compared to 1996 (n = 39) [ Figure 13 ].
Between 1996 and 2015, there were 1277 cases of thyroid cancer reported in Oman: 242 in men and 1035 in women. The ASR by gender were 2.0 cases per 100 000 Omani males and 7.6 cases per 100 000 females [ Tables 5 and 6 
Five common cancer in Omani male
Between 1996 and 2015, prostate cancer was observed to be the leading malignancy in Omani males (998 new cases), followed by cancers of the stomach, NHl, leukemia, and colorectal. Table 10 summarizes the five most common cancers in Omani male in three different periods 1996-2005, 2006-2015, and over 20 years 1996-2015. 
1) Prostate cancer
Prostate cancer was the leading cancer in Omani males between 1996 and 2015 and accounting for 9.3% of all incident cases in males with an average annual ASR of 11.6/100 000 people [ Tables 5  and 10 ]. Prostate cancer incidence continued to rise slowly over the years; the lowest ASR (6.9/100 000) was reported in 2003 and the highest (17.0/100 000) in 2011 [ Table 7 ]. Age-specific incidence among males begins in the age group 40-45 year and steadily rises to peak in the in the age group 70-74 year [ Table 5 ].
2) Stomach cancer
Stomach cancer was the second most common cancer in Omani males between 1996 and 2015 and accounting for 8.9% of all incident cancers in males with an average annual ASR of 10.9 /100 000 male [ Table 5 ]. The trend of stomach cancer incidence had declined over the years; the lowest ASR (5.7/100 000) was reported in 2015 and the highest in the 25-30 year age group and steadily rises to peak in the 60-65 year age group [ Table 5 ].
Five common cancer in Omani female
Between 1996 and 2015, breast cancer was the leading malignancy in Omani females with 2181 new cases, followed by cancers of the, thyroid, colorectal, NHl, and leukemia. 
1) Breast cancer
Breast cancer was by far the most common cancer among Omani females and accounted for 21.2% of all incident cases between 1996 and 2015, with an average annual ASR of 20.8/100 000 women [ Table 6 ]. Its incidence has increased over the past 20-year period [ Figure 17 ]. The lowest ASR (13.2/100 000) was noted in 1998 and the highest (26.9/100 000) was in 2015 [ Table 8 ]. The agespecific incidence rates among female begins to rise in the second to third decades of life with steadily rises to peak in the fourth and fifth decade years [ Table 6 ].
2) Thyroid cancer
Thyroid cancer was the second most common female cancer between 1996 and 2015 and accounted for 10.0% of all incident cancer cases in Omani female, with an average annual ASR of 7.6/100 000 people [ Figure 18 ]. Thyroid cancer incidence continued to rise steadily over the years; the ASR was lowest (4.3/100 000) in 2000 and highest (14.3/100 000) in 2015 [ Table 8 ]. Cases were seen in females as young as 15 years of age, and incidence was found to increase with age, with peaks at 30-45 years and at 65-70 years [ Table 6 ].
3) Colorectal cancer
Colorectal cancer is the third most common cancer in females and accounted for 5.9% of all incident 0 6
